Supernus, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
28.00
-0.35 (-1.23%)
Nov 20, 2026, 8:35 AM EST - Market open
Supernus Employees
As of December 31, 2025, Supernus had 838 total employees, including 827 full-time and 11 part-time employees. The number of employees decreased by 213 or 20.27% compared to the previous year. That makes Supernus the 16,201st largest employer in the world and 2,299th in the United States.
Employees
838
Change (1Y)
-213
Growth (1Y)
-20.27%
Revenue / Employee
$1,639,618
Profits / Employee
$536,993
Market Cap
5.82B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 838 | -213 | -20.27% | 827 | 11 |
| Dec 31, 2024 | 1,051 | -113 | -9.71% | 1,030 | 21 |
| Dec 31, 2023 | 1,164 | 236 | 25.43% | 1,164 | 0 |
| Dec 31, 2022 | 928 | 43 | 4.86% | 928 | 0 |
| Dec 31, 2021 | 885 | 97 | 12.31% | 885 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Bausch Health Companies | 20,300 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Lantheus Holdings | 1,193 |
| Xeris Biopharma Holdings | 435 |
SUPN News
- 4 hours ago - Supernus initiated with an Overweight at Wells Fargo - TheFly
- 4 days ago - Supernus Transcript: Jefferies Global Healthcare Conference - Transcripts
- 10 days ago - Supernus, Inc. to Participate in the 2026 Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 11 days ago - Supernus initiated with a Buy at BofA - TheFly
- 11 days ago - Supernus initiated with a Buy at BofA - TheFly
- 16 days ago - Supernus price target raised to $87 from $67 at Cantor Fitzgerald - TheFly
- 16 days ago - Supernus resumed with an Overweight at Piper Sandler - TheFly
- 16 days ago - Supernus price target lowered to $37 from $55 at Stifel - TheFly